Form 4: ACM Research CFO Exercises Options and Sells Shares Under 10b5-1 Plan

Mark McKechnie, CFO of ACM Research, exercised stock options and sold shares of Class A Common Stock on June 6, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On June 6, 2024, Mark McKechnie, the CFO of ACM Research, exercised stock options to acquire 14,016 shares and 5,984 shares of Class A Common Stock at exercise prices of $4.62 and $5.60, respectively.
• Concurrently, McKechnie sold 14,016 shares and 5,984 shares at a weighted average price of $22.92.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on March 7, 2024.
• Following these transactions, McKechnie directly owns 900 shares of Class A Common Stock.
• McKechnie also holds options for 61,516 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock option exercises and share sales.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives to use Rule 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The semiconductor industry is closely watched for such transactions.

Comparison to Industry Standards

• Executive compensation practices, including stock options and trading plans, are common across the semiconductor industry.
• Companies like Applied Materials (AMAT) and Lam Research (LRCX) also have executives who utilize 10b5-1 trading plans.
• The size and frequency of these transactions are typical for executives at publicly traded companies.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
• The impact is likely minimal given the relatively small number of shares involved and the pre-planned nature of the sales.

Key Dates